Octreotide long-acting repeatable for acromegaly. - Wikidata - awgldk - TriplyDB

Octreotide long-acting repeatable for acromegaly.

Octreotide long-acting repeatable for acromegaly.

http://www.wikidata.org/entity/Q37990556

about

Preservation of blood glucose homeostasis in slow-senescing somatotrophism-deficient mice subjected to intermittent fasting begun at middle or old age.Peptide receptor targeting in cancer: the somatostatin paradigm.

P2860

Q33848749-0C58F2B9-E6C5-490E-83EB-27F15A757095 Q36638046-2D2ECC51-95A1-4AB5-8491-40C83863F24A

P2860

Octreotide long-acting repeatable for acromegaly.

http://www.wikidata.org/entity/Q37990556

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Octreotide long-acting repeatable for acromegaly.

@en

Octreotide long-acting repeatable for acromegaly.

@nl

type

label

Octreotide long-acting repeatable for acromegaly.

@en

Octreotide long-acting repeatable for acromegaly.

@nl

prefLabel

Octreotide long-acting repeatable for acromegaly.

@en

Octreotide long-acting repeatable for acromegaly.

@nl

P1433

Q37990556-312335CC-66E6-4EA6-BCC6-A5EC2652E62D

P1476

Q37990556-49E06E11-205A-4815-BB05-93C742AD7BED

P2093

Q37990556-F1CF58B3-022C-419D-A8B7-0E29FF923743

Q37990556-F6DC5CD3-F7F0-430C-8E72-D9FDD0646CA0

P2860

Q37990556-006EF796-07D0-4B15-AE8D-07324E3BA208

Q37990556-020E545D-F648-4392-8200-3488A77C5EEC

Q37990556-02B3B3C7-190C-471A-82FA-8A8634A8A145

Q37990556-045D8D98-B0B6-4994-8CA3-815033612284

Q37990556-05E9CB30-64AF-4392-9FC3-5487C213E999

Q37990556-096A2BE6-24C8-487E-A083-9B7EDC644BED

Q37990556-0A0187B7-A449-438B-A65F-8710B1B8EAD3

Q37990556-0AAA28F7-ABB7-42E7-B8F1-CF29F1AA3C99

Q37990556-0CA1B57C-E905-4DF9-90C5-28BA4A4183B0

Q37990556-0DEF6622-6DB6-4C1D-9A46-670B1FE70730

P304

Q37990556-FE92E734-DB9B-41C7-8D5E-95DA05EDFC9F

P31

Q37990556-1B728663-7EA8-4B07-889B-E35C1F3EBABC

P356

Q37990556-E5390940-8D8B-4888-B34D-72ADA6D9C182

P407

Q37990556-7D0FA246-A690-4C88-9432-19CF342764CD

P433

Q37990556-12599130-CE40-4744-8018-433920D2B108

P478

Q37990556-45C3B2FE-9510-4299-8169-A9E251E74030

P577

Q37990556-D861A48C-0D5A-4DD2-99AA-F0570515F483

P698

Q37990556-8245AF85-53A5-48C9-8DEA-47B307C94E42

P356

P1433

Expert Review of Clinical Pharmacology

P1476

Octreotide long-acting repeatable for acromegaly.

@en

P2093

Renato Cozzi

http://www.w3.org/2001/XMLSchema#string

Roberto Attanasio

http://www.w3.org/2001/XMLSchema#string

P2860

A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers.

Airway smooth muscle prostaglandin-EP1 receptors directly modulate beta2-adrenergic receptors within a unique heterodimeric complex

Acromegaly pathogenesis and treatment

Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers

Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study

Gallbladder function in acromegalic patients taking long-term octreotide: evidence of rebound hypermotility on cessation of treatment

Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly

Gender differences in secretory activity of the human somatotropic (growth hormone) axis.

Preliminary data on biochemical remission of acromegaly after somatostatin analogs withdrawal.

Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone.

P304

125-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ECP.12.4

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22390555

http://www.w3.org/2001/XMLSchema#string